Your Source for epilepsy Information
 

Endocrinology Programming

All programs are available on VHS videotapes as well as DVDs ($35 charge for conversion to other formats). For orders over 20 items, please contact us directly to obtain shipping rates.

Program
Title
Time
Price
MB-0329N
Diabetes: DCCT
90 min
$249.00

Barbara Walz, RN, BSN, CDE; Jerome Fischer, MD; Christy Franckoviak, RD

Disease management of diabetes, w/ special emphasis given to the results of the DCCT trial and tight glucose control. Intensive insulin management and insulin pump therapy will also be discussed.
MB-0509M
Obstetrics & Gynecology: Understanding the Role of Estrogen
90 min.
$249.00

Wulf H. Utian, MD, PhD; Frank Bellino, PhD; Arie Birkenfeld, MD; Matan Yemini, MD; Mary Ellen Kennedy, RN

Comprehensive Health Care to the Peri-Menopause; Current Research Trends; Hormone Replacement Therapy; What is Menopause?; Nursing Perspectives in Menopause Management.
MB-0614M
Obgyn Update: GnRH Agonists & the Role of Add-back Therapy
90 min.
$249.00

John A. Rock, MD; William D. Schlaff, MD; Deborah A. Metzger, PhD, MD

Implications of add-back therapy to the length of treatment with the GnRH agonists; The appropiate time to initiate add-back therapy on a patient being treated with GnRH agonists; Diseases which can be treated with add-back therapy; Candidate profile for add-back therapy.

MB-1109M
Diabetes Update: Advances in Research Therapy  
60 min
$209.00

Brian R. Tulloch, MD; Craig Hanis, PhD; Sherwyn L. Schwartz, MD; Stanley Feld, MD

Diabetes and kidney disease current and future therapy; diabetes control and complications trials; complications and mortality rate among Mexican Americans with Type 2; introduce a system for intensive self management of Diabetes Mellitus.
MC-0327M
Current Issues in the Hormonal Treatment of Breast Cancer
60 min.
$209.00

Harold Harvey, MD; Richard Santen, MD; Paul Goss, MD; Andrea Manni, MD

Topics covered in this program include: new aromatase inhibitors; risks and benefits of adjuvant tamoxifen; potential prevention of breast cancer by hormonal therapies; optimal duration therapy with tamoxifen; post-menopausal estrogen replacement therapy.

MC-0911M
Advances in Management of Weight Loss
60 min.
$209.00

Alan R. Shuldiner, MD; Richard L. Atkinson, MD; F. Xavier Pi-Sunyer, MD; George Bray, MD

Overview of Genetics in People of Obesity; Treatment of Obesity with Drugs; Health Risks Related to Obesity; Prevelance & Mechanism of Obesity.
MD-0327N
Management of the Diabetic Patient While Tube Feeding     
60 min.
$209.00

Leigh B. Bak, RN, MS, CDE; Kathy Heard, RN, MSN; Genevieve P. Kearney, MS, RD, CD-N

This program identifies situations when enteral nutrition via tube feeding would be indicated; identifies appropriate enteral formulas for diabetic patients receiving tube feedings; discusses complications of tube feedings and strategies to avoid and or minimize risks; states and issues unique to managing the diabetic patient who is being tube fed; identifies strategies to maintain acceptable blood sugars in patients with diabetes on enteral feedings.

MD-0520P
Rationale for Achieving Optimal Glycemic Control in Diabetic Patients      
60 min.
  $209.00

R. Keith Campbell, RPh, FASHP, CDE; Julie C. Oki, PharmD, BCPS

Provide an update on the treatment of diabetes, including a review of the rationale for and means of achieving optimal glycemic control. Specific topics covered include: Discussion of the rationale for achieving optimal glycemic control in both type I and type II diabetic patients; Recent advances which may aid in achieving optimal glycemic control in type II diabetic patients; Methods to improve glycemic control in patients with type I diabetes.

00-0301M
Treatment of type 2 Diabetes Mellitus: a Sound Approach Based Upon its Pathophysiology      
60 min.
$209.00

Ralph A. DeFronzo, MD

This program is designed to give family care physicians, as well as other healthcare professionals, a better understanding of diabetes mellitus. The program features a leading medical expert giving a presentation on the treatment of Type 2 diabetes based upon its pathophysiology. The program also addresses goals for treatment, currently available medications and the prevention of complications

 

 

This healthcare portal website has been created as a source of objective and credible health and medical information for healthcare professionals and consumers and does not endorse any specific product, service or organization. MEDIVISION does not warrant the accuracy of this information, and it is intended as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of healthcare professionals. If you have questions about health care, please consult a physician or other health care professional.
COPYRIGHT © MEDIVISION, 2011